Albuterol and saline nebulizer therapy
Pro Research Analysisby 
Searched over 200M research papers
Albuterol and Saline Nebulizer Therapy: Clinical Uses and Comparative Effectiveness
Albuterol Nebulizer Therapy for Asthma and Bronchiolitis
Albuterol, a beta-2 agonist, is widely used via nebulization to treat acute asthma and wheezing in children and adults. Studies show that nebulized albuterol leads to significant improvements in clinical status, including respiratory rate, wheezing, accessory muscle use, and oxygen saturation in infants and young children with acute asthma or bronchiolitis compared to saline placebo Schuh1990Bentur1992. These improvements are observed after one or two doses, and the therapy is generally safe, with minimal side effects such as a slight increase in heart rate Schuh1990Bentur1992.
However, in hospitalized infants with moderate bronchiolitis, nebulized albuterol does not significantly enhance recovery, oxygen saturation, or reduce hospital stay compared to saline . Similarly, in infants with acute viral bronchiolitis, repeated nebulized albuterol or saline does not show differences in length of hospital stay or time to clinical improvement . These findings suggest that while albuterol may provide short-term symptom relief in some cases, its routine use in all bronchiolitis cases is not supported.
Albuterol vs. Saline and Other Nebulized Solutions
When comparing albuterol mixed with saline to other combinations, such as albuterol with ipratropium, studies in acute asthma patients show no significant long-term difference in lung function improvement or need for additional therapy between the two groups . This indicates that albuterol with saline is effective on its own for most patients in acute settings.
In the context of bronchiolitis, nebulized hypertonic saline (3%) has been studied as an alternative to normal saline. However, infants with bronchiolitis and persistent respiratory distress after standard treatment showed less improvement with hypertonic saline compared to normal saline, and there were no differences in hospitalization rates or adverse events . This suggests that normal saline remains the preferred diluent for nebulized therapies in this setting.
Albuterol Nebulizer Therapy in Other Clinical Scenarios
Nebulized albuterol has also been evaluated as an adjunct therapy in acute anticholinesterase pesticide poisoning. In this context, albuterol was found to be safe and may improve oxygenation in moderately intoxicated patients compared to saline .
For patients on hemodialysis with acute hyperkalemia, nebulized albuterol significantly reduces plasma potassium levels without causing adverse cardiovascular effects, while nebulized saline does not affect potassium levels . This highlights a unique and important use of albuterol nebulization beyond respiratory conditions.
Continuous Nebulized Albuterol in Acute Lung Injury
In animal models of combined burn and smoke inhalation injury, continuous nebulized albuterol improved pulmonary function, airway clearance, and reduced lung fluid compared to saline . These findings support the potential for albuterol nebulization in managing acute lung injury, though more research is needed in human subjects.
Conclusion
Albuterol nebulizer therapy, typically delivered with normal saline, is effective and safe for acute asthma and provides short-term benefits in some cases of bronchiolitis and other acute conditions. However, its routine use in all cases of bronchiolitis is not supported by evidence, and normal saline remains the preferred diluent for nebulized therapies. Albuterol also has important roles in treating acute hyperkalemia and as an adjunct in specific poisonings, further broadening its clinical utility Karpel1996Zein-Elabdeen2024Florin2014+6 MORE.
Sources and full results
Most relevant research papers on this topic